Other names: Eldepryl®, Zelapar®
Categories: Prescription Medication
Description:
Selegiline (Eldepryl®, Zelapar®) is a MAO-B inhibitor used in Parkinson’s disease to slow the breakdown of dopamine in the brain. It can be prescribed alone in early stages for mild symptom relief or added to levodopa to help reduce “wearing-off” fluctuations. Selegiline may provide modest improvements in motor symptoms and daily functioning, though it is generally less potent than other therapies. Common side effects include insomnia, nausea, dizziness, and headache, and it should be taken earlier in the day to avoid sleep problems. While not a first-line treatment, selegiline can be a helpful adjunct for managing Parkinson’s symptoms.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment "Selegiline" against Parkinson's Disease. The effectiveness of this treatment cannot be determined due to the lack of ratings and reviews. More data is needed to assess the efficacy of Selegiline in managing Parkinson's Disease symptoms.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
